Fatal bone marrow embolism in a patient with sickle cell beta + thalassaemia.
AUTOR(ES)
Zaidi, Y
RESUMO
Sickle cell beta + thalassaemia is regarded as the mildest of the sickle cell haemoglobinopathy syndromes with a benign natural course. In contrast to sickle cell disease, severe life threatening complications are not usually associated with this genotype. A case of a 30 year old West Indian man who, previously asymptomatic for 10 years, sustained a fatal pulmonary bone marrow embolism, is reported. This case report illustrates that serious, even fatal, complications may occur in patients with this 'benign' condition and bone marrow embolism should be included in the differential diagnosis of acute crisis in these patients.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=500734Documentos Relacionados
- Bone marrow and peripheral blood globin chain synthesis in sickle cell beta zero thalassaemia.
- Serum amyloid A protein concentration in bone marrow transplantation for beta thalassaemia.
- Fatal Campylobacter jejuni infection in a patient splenectomised for thalassaemia.
- Red cell genetic abnormalities in Peninsular Arabs: sickle haemoglobin, G6PD deficiency, and alpha and beta thalassaemia.
- Pitfalls in prenatal diagnosis of beta thalassaemia.